E
Elisabeth Cassuto-Viguier
Researcher at University of Nice Sophia Antipolis
Publications - 11
Citations - 1011
Elisabeth Cassuto-Viguier is an academic researcher from University of Nice Sophia Antipolis. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 7, co-authored 11 publications receiving 894 citations.
Papers
More filters
Journal ArticleDOI
Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.
Nassim Kamar,Nassim Kamar,Cyril Garrouste,Elizabeth B. Haagsma,Valérie Garrigue,Sven Pischke,Cecile Chauvet,Jérôme Dumortier,Amelie Cannesson,Elisabeth Cassuto-Viguier,Eric Thervet,Filomena Conti,Pascal Lebray,Harry R. Dalton,Robert N. Santella,Nada Kanaan,Marie Essig,Christiane Mousson,Sylvie Radenne,Anne Marie Roque-Afonso,Jacques Izopet,Jacques Izopet,Lionel Rostaing,Lionel Rostaing +23 more
TL;DR: A retrospective analysis of data from 17 centers from Europe and the United States that described the progression, outcomes, and factors associated with development of chronic HEV infection in recipients of transplanted solid organs found tacrolimus therapy is the main predictive factor for chronic hepatitis.
Journal ArticleDOI
B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
Olivier Thaunat,Natacha Patey,Chantal Gautreau,Sophie Lechaton,Véronique Frémeaux-Bacchi,Marie-Caroline Dieu-Nosjean,Elisabeth Cassuto-Viguier,Christophe Legendre,Michel Delahousse,Philippe Lang,Jean-Baptiste Michel,Antonino Nicoletti +11 more
TL;DR: In certain patients, inflammatory microenvironment provides BAFF-dependent paracrine survival signal to B-cells in TLOs, allowing them to escape rituximab-induced apoptosis, thereby thwarting therapeutic efficiency.
Journal ArticleDOI
Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy
Gabriel Choukroun,Nassim Kamar,Bertrand Dussol,Isabelle Etienne,Elisabeth Cassuto-Viguier,Olivier Toupance,François Glowacki,Bruno Moulin,Yvon Lebranchu,Guy Touchard,Maïté Jauréguy,Nicolas Pallet,Yannick Le Meur,Lionel Rostaing,Frank Martinez +14 more
TL;DR: It is suggested that targeting hemoglobin values ≥13 g/dl reduces progression of chronic allograft nephropathy in kidney transplant recipients and is associated with a significant improvement in quality of life at 6 and 12 months.
Journal ArticleDOI
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study.
F. Martinez,Nassim Kamar,Nicolas Pallet,Peter Lang,Antoine Durrbach,Yvon Lebranchu,A. Adem,S. Barbier,Elisabeth Cassuto-Viguier,F. Glowaki,Y. Le Meur,Lionel Rostaing,Ch. Legendre,Olivier Hermine,Gabriel Choukroun +14 more
TL;DR: A French open‐label multicenter randomized study to evaluate the effect of high doses of epoetin beta (EPO‐β) during the first 2 weeks of renal transplantation on renal function in patients at risk for delayed graft function (DGF).
Journal ArticleDOI
Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study
Luc Frimat,Elisabeth Cassuto-Viguier,Bernard Charpentier,Christian Noel,François Provôt,Lionel Rostaing,Denis Glotz,Jean-Daniel Sraer,Bernard Bourbigot,Bruno Moulin,Philippe Lang,Didier Ducloux,Claire Pouteil-Noble,Sandrine Girardot-Seguin,Michèle Kessler +14 more
TL;DR: The impact of the introduction of MMF combined with cyclosporine (CsA) 50% dose reduction on renal function improved significantly in the MMF group and one patient in each group lost his graft because of biopsy‐proven chronic allograft nephropathy.